CGM sensors with type 2 diabetes: who gets them covered in Norway
The criteria for getting a glucose sensor covered with type 2 diabetes, how to apply via the hospital, what Diabetesforbundet demands and what buying one costs.
General information, not medical advice. Make changes to diet, activity and medication together with your doctor. Read more. Translated from the Norwegian original. Sources are Norwegian pages. Rules and rates apply to Norway.
A sensor (CGM) is not covered by blue prescription (blå resept) for type 2 diabetes, and your GP cannot prescribe it. It is lent out by the hospital as a treatment aid, and as of 2026 that only applies to people on insulin with hard-to-control blood sugar and repeated hypos, severe kidney failure with insulin treatment, or pregnancy. A national decision for type 2 has been postponed.
Two different schemes
Diabetes equipment is funded in two ways in Norway, and that explains why a sensor is harder to get than test strips.
| Blue prescription (blå resept, Helfo) | Treatment aids (behandlingshjelpemidler, the hospital) | |
|---|---|---|
| What | Test strips, lancets, pen needles, medicines | Insulin pump, continuous glucose monitor (CGM), consumables for these |
| Who prescribes | Your GP (fastlege) | A doctor in the specialist health service |
| Co-payment (egenandel) | Yes, counts towards the exemption card (frikort) | No |
| Budget | The National Insurance scheme | The individual health trust |
A continuous glucose monitor, often called a sensor or CGM, is therefore not something your GP can prescribe. That applies to FreeStyle Libre, Dexcom and other systems alike.
Who with type 2 can get a sensor as of 2026
For type 1 diabetes, sensors were approved for everyone in 2023. For type 2 there is still no national decision. Instead, temporary group exemptions apply, which Diabetesforbundet (the Norwegian Diabetes Association) summarises as follows (as of May 2026):
- insulin-dependent type 2 diabetes with hard-to-control blood sugar and repeated episodes of low blood sugar
- severe kidney failure with insulin treatment and high risk of low blood sugar
- pregnant women with a medical indication
- gestational diabetes with a medical indication
Approval requires assessment by a specialist group or the medical director at the health trust. Diabetesforbundet states plainly that it can be difficult to have the application approved, and that access varies with where you live and what practice the hospital follows.
If you do not use insulin, you fall outside the criteria. The guideline from Helsedirektoratet (the Norwegian Directorate of Health) also says that most people with type 2 who do not use insulin do not need frequent self-monitoring. That does not mean measuring is pointless, but it explains why the public health service does not yet prioritise sensors for this group.
How to apply
- Talk to your GP. If you are treated only by your GP, you must first be referred to a diabetes outpatient clinic or another specialist. Describe concretely why finger-prick testing is not enough: frequent hypos (føling), night-time episodes, multiple daily insulin injections, shift work or an occupation where low blood sugar is dangerous.
- The hospital doctor assesses whether you meet one of the group exemptions.
- The doctor fills in the form “Utlån av behandlingshjelpemidler og utlevering av forbruksmateriell” (loan of treatment aids and supply of consumables) and sends it to the treatment aids unit at the health trust. Sensors and other consumables are applied for at the same time.
- Decision. If you are refused, ask for a written justification. Diabetesforbundet always recommends asking for a written refusal, because it can be used in an appeal. The appeal is sent to whoever refused, and goes on to the County Governor (Statsforvalteren) if the hospital does not reverse the decision.
Diabetesforbundet is a member of FFO, and members can get help from FFO’s rights centre in such cases. See Help and support.
Where the case stands
Nye metoder (the national system for managed introduction of new health technologies) has assessed CGM and flash glucose monitoring for type 2 diabetes. Beslutningsforum (the decision-making forum of the regional health authorities) was due to decide the case on 18 May 2026, but postponed it to clarify funding and how much health personnel is needed for training and follow-up. Until the case is considered again, the group exemptions above apply.
Diabetesforbundet is critical of the health technology assessment. They believe it underestimates the benefit, overestimates the training need, and that the group exemptions are too strict. The association’s main demand, formulated in September 2025, is that CGM must be moved into the blue prescription scheme and funded by Helfo (the Norwegian Health Economics Administration), as test strips are today. Then the hospital’s budget will not decide who gets a sensor. They also demand that the national diabetes guideline is updated so that it becomes clear who with type 2 should be offered CGM, and that quality of life and self-management should count in the assessment.
Buying yourself
If you do not meet the criteria, you can buy a sensor yourself. Diabetesforbundet wrote in 2019 that a FreeStyle Libre sensor for 14 days cost about NOK 600, that is around NOK 15,000 a year. Prices have changed since, and not all models are sold freely at pharmacies, so check the current price and availability where you shop. The expense does not count towards the exemption card.
Some people use a sensor for a shorter period, for example two to four weeks, to learn how food, activity and sleep affect their blood sugar. Talk to your GP about what to look for, and whether it is worth the cost for you. What is covered in the way of finger-prick equipment is explained in Glucose meters and test strips on blue prescription.
Frequently asked questions
Is FreeStyle Libre covered for type 2 diabetes?
Only in specific cases. As of 2026, people with type 2 who use insulin, have poorly controlled blood sugar and repeated episodes of low blood sugar can be considered for a sensor through the hospital's treatment aids scheme. The same applies to severe kidney failure with insulin treatment and to pregnancy.
Can my GP prescribe a sensor on blue prescription?
No. Sensors are not in the blue prescription scheme. They are covered as a treatment aid from the hospital, and you must be referred to the specialist health service for a doctor there to be able to apply.
What does it cost to buy a glucose sensor yourself?
Diabetesforbundet stated in 2019 that a FreeStyle Libre sensor for 14 days cost around NOK 600, which comes to about NOK 15,000 a year. Prices change, so check the current price at the pharmacy.
Do I pay a co-payment for a sensor from the hospital?
No. Treatment aids from the hospital carry no co-payment. Sensors and other consumables are supplied by the treatment aids unit for as long as the decision is valid.
Will CGM come to everyone with type 2 diabetes?
That has not been decided. Beslutningsforum postponed the case on CGM for type 2 in May 2026 to clarify funding and staffing needs. Diabetesforbundet demands that CGM is moved into the blue prescription scheme and that the criteria for type 2 are made clearer.
Sources
- Rett til insulinpumpe eller sensor (behandlingshjelpemidler) · Diabetesforbundet
- Beslutning om CGM til diabetes type 2-pasienter utsettes · Diabetesforbundet
- Diabetesforbundet mener: CGM må inn i blåreseptordningen · Diabetesforbundet
- Alle trenger tilgang til utstyr som passer for seg · Diabetesforbundet
- FreeStyle Libre til tusenvis · Diabetesforbundet
- Egenmåling av blodsukker ved diabetes type 2 · Helsedirektoratet
Caveat. The content on this page is general information and not medical advice. It does not replace examination, diagnosis or treatment by a doctor. Changes to diet, physical activity, weight or medication should always be made together with your GP or other health professional. Do not change or stop medication on your own. Contact your GP or the out-of-hours clinic (116 117) if you are worried, and call 113 in an emergency. Read the full disclaimer.